Skip to content

Clinical trials

Dermatomyositis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Country / region: United States Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20031
20051
20062
20082
20091
20102
20112
20121
20134
20143
20156
20161
20175
20184
20193
20203
20214
20223
20236
20248
202511
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Recruiting26
Terminated11
Withdrawn3
Not yet recruiting3
Active, not recruiting3
Unknown status2
Approved for marketing1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)8
National Institute of Environmental Health Sciences (NIEHS)6
Pfizer4
Duke University3
Novartis Pharmaceuticals3
argenx3
Amgen2
AstraZeneca2
Bristol-Myers Squibb2
Children's Hospital Medical Center, Cincinnati2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis94
Polymyositis39
Myositis35
Lupus Erythematosus, Systemic16
Scleroderma, Systemic16
Arthritis, Rheumatoid14
Autoimmune Diseases13
Scleroderma, Diffuse9
Sjogren's Syndrome8
Arthritis, Juvenile7

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.